Use of comparative effectiveness research for similar Chinese patent medicine for angina pectoris of coronary heart disease: a new approach based on patient-important outcomes

Table 2 Efficacy assessment by category of multiple symptom combinations

Multiple symptom combinations	Four groups of patients categorized using the efficacy assessment tool
Multiple symptom combinations	Group 1	Group 2	Group 3	Group 4
Combination (1 + 2)	(AB1 + AB2)/2 N	(A1 + A2)/2 N	(B1 + B2)/2 N	(ab1 + ab2)/2 N
Combination (1 + 3)	(AB1 + AB3)/2 N	(A1 + A3)/2 N	(B1 + B3)/2 N	(ab1 + ab3)/2 N
Combination (1 + 4)	(AB1 + AB4)/2 N	(A1 + A4)/2 N	(B1 + B4)/2 N	(ab1 + ab4)/2 N
Combination (2 + 3)	(AB2 + AB3)/2 N	(A2 + A3)/2 N	(B2 + B3)/2 N	(ab2 + ab3)/2 N
Combination (2 + 4)	(AB2 + AB4)/2 N	(A2 + A4)/2 N	(B2 + B4)/2 N	(ab2 + ab4)/2 N
Combination (3 + 4)	(AB3 + AB4)/2 N	(A3 + A4)/2 N	(B3 + B4)/2 N	(ab3 + ab4)/2 N
Combination (1 + 2 + 3)	(AB1 + AB2 + AB3)/3 N	(A1 + A2 + A3)/3 N	(B1 + B2 + B3)/3 N	(ab1 + ab2 + ab3)/3 N
Combination (1 + 2 + 4)	(AB1 + AB2 + AB4)/3 N	(A1 + A2 + A4)/3 N	(B1 + B2 + B4)/3 N	(ab1 + ab2 + ab4)/2 N
Combination (1 + 3 + 4)	(AB1 + AB3 + AB4)/3 N	(A1 + A3 + A4)/3 N	(B1 + B3 + B4)/3 N	(ab1 + ab3 + ab4)/3 N
Combination (2 + 3 + 4)	(AB2 + AB3 + AB4)/3 N	(A2 + A3 + A4)/3 N	(B2 + B3 + B4)/3 N	(ab2 + ab3 + ab4)/3 N
Combination (1 + 2 + 3 + 4)	(AB1 + AB2 + AB3 + AB4)/4 N	(A1 + A2 + A3 + A4)/4 N	(B1 + B2 + B3 + B4)/4 N	(ab1 + ab2 + ab3 + ab4)/4 N

ISSN: 1745-6215